Chi-Iou Lin
Center for Vascular Biology Research,
Department of of Pathology,
Beth Israel Deaconess Medical Center,
Center for Vascular Biology Research, Department of of Pathology, Beth Israel Deaconess Medical Center
Harvard Medical School
Chi-Iou Lin has not added Biography.
If you are Chi-Iou Lin and would like to personalize this page please email our Author Liaison for assistance.
Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.
American journal of physiology. Cell physiology Dec, 2004 | Pubmed ID: 15294853
Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells.
Endocrinology Aug, 2005 | Pubmed ID: 15878967
Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism.
Journal of cellular biochemistry Nov, 2006 | Pubmed ID: 16795034
Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3.
Biochemical and biophysical research communications Apr, 2007 | Pubmed ID: 17331465
Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
Biochemical and biophysical research communications Nov, 2007 | Pubmed ID: 17923111
Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells.
Biochemical and biophysical research communications Feb, 2008 | Pubmed ID: 18167312
Establishment of a fluorescence resonance energy transfer-based bioassay for detecting dioxin-like compounds.
Journal of biomedical science Nov, 2008 | Pubmed ID: 18604597
Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
Cellular signalling Oct, 2008 | Pubmed ID: 18627789
Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.
Biochemical and biophysical research communications Feb, 2009 | Pubmed ID: 19124005
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.
Molecular cancer research : MCR Oct, 2009 | Pubmed ID: 19825987
Autophagy: a new target for advanced papillary thyroid cancer therapy.
Surgery Dec, 2009 | Pubmed ID: 19958950
Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.
Thyroid : official journal of the American Thyroid Association Jun, 2010 | Pubmed ID: 20470206
Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.
Molecular cancer research : MCR Sep, 2010 | Pubmed ID: 20736296
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
The Journal of clinical endocrinology and metabolism Mar, 2011 | Pubmed ID: 21190978
Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.
Surgery Dec, 2011 | Pubmed ID: 22136818
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.
Surgery Dec, 2011 | Pubmed ID: 22136853
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.
Biochemical and biophysical research communications May, 2012 | Pubmed ID: 22521882
Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma.
Surgery Dec, 2012 | Pubmed ID: 23102636
Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer.
Surgery Dec, 2012 | Pubmed ID: 23158184
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유